Stephen J. Schueler, M.D.

Overview Incidence Symptoms Evaluation Treatment specialist Outlook Complications Underlying Cause Anatomy

Cherry Hemangioma Overview

Another name for Cherry Hemangioma is Hemangiomas.

What are hemangiomas?
A person with a hemangioma or angioma has a collection of small blood vessels that forms a bright red or purple area on the skin. These benign tumors are derived from the cells that line blood vessels or lymphatic vessels. Hemangiomas can be present at birth or develop later in life. About 1 out every 10 infants in the US is born with a hemangioma. Up to 50 percent of all hemangiomas resolve by age five, and as many as 90 percent resolve by age nine. The underlying cause of hemangiomas is unknown.

What are the symptoms of hemangiomas?
Symptoms of hemangioma include a bright red or purple area on the skin.

How does the doctor treat hemangiomas?
Small hemangiomas in infants resolve without treatment. Small hemangiomas in adults may not resolve, but do not require treatment. The treatment for large hemangiomas may include oral corticosteroids, laser therapy, and surgery to remove the hemangioma.

Continue to Cherry Hemangioma Incidence

Last Updated: Apr 26, 2011 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Cherry Hemangioma References
  1. Enjolras O, Mulliken JB: The current management of vascular birthmarks. Pediatr Dermatol 1993 Dec; 10(4): 311-3. [9039172]
  2. Geronemus RG, Ashinoff R: The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol 1991 Jan; 17(1): 76-9. [1991884]
  3. Goldman MP, Fitzpatrick RE, Ruiz-Esparza J: Treatment of port-wine stains (capillary malformation) with the flashlamp-pumped pulsed dye laser. J Pediatr 1993 Jan; 122(1): 71-7. [8419617]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.